Growth factor binding constructs, materials and methods

Research output: PatentScientific

Abstract

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
Original languageEnglish
Publication Year21 Dec 2010
Publication statusPublished - 21 Dec 2010
MoE publication typeH1 Granted patent

Cite this

Alitalo, K. K., & Jeltsch, M. M. (2010). Growth factor binding constructs, materials and methods. (Patent No. US 7,855,178 B2). US Patent and Trademark Office.
Alitalo, Kari Kustaa (Author) ; Jeltsch, Markku Michael (Author). / Growth factor binding constructs, materials and methods. US Patent and Trademark Office. Patent No.: US 7,855,178 B2. Dec 21, 2010.
@misc{9244a9d578634524bee733a0fc66e324,
title = "Growth factor binding constructs, materials and methods",
abstract = "The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.",
author = "Alitalo, {Kari Kustaa} and Jeltsch, {Markku Michael}",
year = "2010",
month = "12",
day = "21",
language = "English",
publisher = "US Patent and Trademark Office",
address = "United States",
type = "Patent",
note = "US 7,855,178 B2",

}

Growth factor binding constructs, materials and methods. / Alitalo, Kari Kustaa; Jeltsch, Markku Michael.

US Patent and Trademark Office. Patent No.: US 7,855,178 B2. Dec 21, 2010.

Research output: PatentScientific

TY - PAT

T1 - Growth factor binding constructs, materials and methods

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Markku Michael

PY - 2010/12/21

Y1 - 2010/12/21

N2 - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

AB - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

M3 - Patent

M1 - US 7,855,178 B2

Y2 - 2010/12/21

PB - US Patent and Trademark Office

ER -